AlphAIAlphAI — Financial news for AI agents
investing.comNOV 37 min read$HSIC

Henry Schein Q3 2026 slides: profit beats, shares fall on revenue

Henry Schein (HSIC) reported Q3 2026 earnings of $1.56 per share, beating estimates, but revenue of $3.47B missed expectations. Shares fell 5.33% premarket. The company raised full-year EPS guidance to $5.50-$5.56 and highlighted growth in U.S. dental merchandise and margin expansion.

Original reporting
investing.com
Published Nov 3, 2026, 2:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 2:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$HSIC
Neutral
high confidence
Mentioned
$HSIC
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$HSICNeutralMed
01

Why it matters

The key tradable tension is raised full-year profit guidance versus investor focus on revenue trajectory and the sustainability of growth, reflected in the premarket selloff.

02

Market read

Traders can reassess near-term expectations for revenue growth and EPS quality after the guidance raise and the market’s revenue-focused reaction.

03

What to watch

Investors may be underweighting the non-recurring tariff refund benefit and the assumption of no further refunds, which could affect forward EPS quality.

Relevance 8/10Novelty 8/10Timing: premarket reaction on Nov. 3, 2026 after Q3 results and guidance raise

Background

Henry Schein’s Q3 2026 results combined a non-GAAP EPS beat with a slight revenue miss, alongside a value-creation program and technology/practice-management initiatives.

Company-level read

Ticker impact

$HSICNeutralHigh confidence
Context

Henry Schein reported Q3 non-GAAP EPS of $1.56 vs $1.36 consensus, but revenue missed and shares fell 5.33% premarket.

Expected impact

Likely choppy trading, with downside risk if investors focus on the revenue shortfall and tariff-related EPS normalization.

Evidence & confidence

The article ties the premarket selloff to the modest revenue miss and growth outlook, while also noting raised full-year EPS guidance and margin expansion.

Market effects

Sector

Signals continued margin resilience in healthcare distribution and practice-management software, but highlights sensitivity to revenue growth and tariff normalization.

Regional

Primarily US-focused read-through given the distributor’s US dental merchandise strength and US premarket reaction.

Global

Limited broader global impact beyond healthcare services/distribution sentiment.

Counterpoint

What could challenge this read

The profit beat and raised EPS guidance may outweigh the revenue miss if margin expansion and share gains persist into Q4.

Key entities

  • company
    Henry Schein

    Healthcare products distributor reporting Q3 2026 results, margin expansion, and raised full-year non-GAAP EPS guidance.

Read at source← All news

StoryHenry Schein beats Q3 profit estimates and raises FY2026 guidance

Also covered by

5 outlets

Related articles

NOV 3
$HSICMedAI 8/10

What Henry Schein (HSIC) Said on Its Q3 Earnings Call

Henry Schein (HSIC) reported Q3 earnings, noting pressure in discretionary procedures but strong growth in global dental and specialty products. U.S. dental equipment sales rose 1.6%, while global distribution and value-added services increased 3.7%. The company raised its non-GAAP EPS outlook to $5.50-$5.56. Management expects 2026 sales growth of 4.5%-5.5% and high-single-digit adjusted EBITDA growth.

finance.yahoo.com6 min
NOV 3
$HSICMedAI 8/10

Henry Schein, Inc. Q3 2026 Earnings Call Summary

Henry Schein reported Q3 2026 US dental merchandise growth of 8.6%, driven by volume. The company targets $200M in operating income improvements by 2026, with $125M expected by year-end. Non-GAAP EPS guidance raised to $5.50–$5.56. Management expects double-digit EPS growth in 2027, supported by value creation initiatives and portfolio shifts. Q3 included a $0.19 per share tariff refund benefit and $22M in restructuring expenses. Emmanuel Capre will succeed Ronald South as CFO in November 2026.

finance.yahoo.com6 min
NOV 3
$HSICHighAI 8/10

HENRY SCHEIN REPORTS STRONG 2026 THIRD QUARTER AND RAISES FY2026 GUIDANCE

HENRY SCHEIN INC (HSIC) filed an SEC Form 8-K — Results of Operations and Financial Condition. -1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS STRONG 2026 THIRD QUARTER AND RAISES FY2026 GUIDANCE ● Q3 2026 GAAP diluted EPS of $1.06, up 26.2% versus prior year; Q3 2026 non-GAAP diluted EPS of $1.56, up 13.0% versus prior year ● 4.0% total sales growth, driven by 8.6% U.

SEC EDGAR 8-K2 min
NOV 3
$HSICHighAI 8/10

Henry Schein Q3 Earnings, Sales Climb; Lifts 2026 Adj. Income Outlook

Henry Schein (HSIC) reported Q3 fiscal 2026 earnings of $1.06 per share, up from $0.84 a year ago, with adjusted profit at $1.37 per share. Revenue rose to $3.471 billion. The company raised its 2026 adjusted earnings outlook to $5.50-$5.56 per share, citing tariff refunds and improved performance. HSIC shares were down 0.14% pre-market.

rttnews.com1 min